NAYAK, AMRUTA PRIYADARSHINI
(2018-05)
Atovaquone, an FDA-approved antimalarial drug and YM155, a drug that has cleared Phase II clinical trials for lung cancer and melanoma, reduce the viability of mouse ovarian cancer cells. Both the drugs induce apoptosis ...